NRP1 and cancer: The interaction of NRP-1 with vascular endothelial growth factor 165 (VEGF165) is an interesting target for novel cancer therapies and several inhibitors of NRP-1/VEGF165 have been proposed as potential drugs such as the heptapeptide A7R.